231 related articles for article (PubMed ID: 37340238)
1. Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.
Davis SE; Zabotka L; Desai RJ; Wang SV; Maro JC; Coughlin K; Hernández-Muñoz JJ; Stojanovic D; Shah NH; Smith JC
Drug Saf; 2023 Aug; 46(8):725-742. PubMed ID: 37340238
[TBL] [Abstract][Full Text] [Related]
2. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?
Coloma PM; Trifirò G; Patadia V; Sturkenboom M
Drug Saf; 2013 Mar; 36(3):183-97. PubMed ID: 23377696
[TBL] [Abstract][Full Text] [Related]
3. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
[TBL] [Abstract][Full Text] [Related]
4. An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records.
Abedian Kalkhoran H; Zwaveling J; van Hunsel F; Kant A
J Med Syst; 2024 May; 48(1):51. PubMed ID: 38753223
[TBL] [Abstract][Full Text] [Related]
5. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records.
Lee S; Choi J; Kim HS; Kim GJ; Lee KH; Park CH; Han J; Yoon D; Park MY; Park RW; Kang HR; Kim JH
J Am Med Inform Assoc; 2017 Jul; 24(4):697-708. PubMed ID: 28087585
[TBL] [Abstract][Full Text] [Related]
8. Pharmacovigilance using clinical notes.
LePendu P; Iyer SV; Bauer-Mehren A; Harpaz R; Mortensen JM; Podchiyska T; Ferris TA; Shah NH
Clin Pharmacol Ther; 2013 Jun; 93(6):547-55. PubMed ID: 23571773
[TBL] [Abstract][Full Text] [Related]
9. On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients.
Duan R; Zhang X; Du J; Huang J; Tao C; Chen Y
Health Informatics J; 2020 Jun; 26(2):753-764. PubMed ID: 30887861
[TBL] [Abstract][Full Text] [Related]
10. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.
Yoon D; Park MY; Choi NK; Park BJ; Kim JH; Park RW
Clin Pharmacol Ther; 2012 Mar; 91(3):467-74. PubMed ID: 22237257
[TBL] [Abstract][Full Text] [Related]
11. Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance.
Lee S; Han J; Park RW; Kim GJ; Rim JH; Cho J; Lee KH; Lee J; Kim S; Kim JH
Drug Saf; 2019 May; 42(5):657-670. PubMed ID: 30649749
[TBL] [Abstract][Full Text] [Related]
12. ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.
Yu Y; Ruddy KJ; Hong N; Tsuji S; Wen A; Shah ND; Jiang G
J Biomed Inform; 2019 Mar; 91():103119. PubMed ID: 30738946
[TBL] [Abstract][Full Text] [Related]
13. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.
Luo Y; Thompson WK; Herr TM; Zeng Z; Berendsen MA; Jonnalagadda SR; Carson MB; Starren J
Drug Saf; 2017 Nov; 40(11):1075-1089. PubMed ID: 28643174
[TBL] [Abstract][Full Text] [Related]
14. An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources.
Shin H; Lee S
BMC Med Inform Decis Mak; 2021 May; 21(1):159. PubMed ID: 34001114
[TBL] [Abstract][Full Text] [Related]
15. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
[TBL] [Abstract][Full Text] [Related]
16. Drug safety data mining with a tree-based scan statistic.
Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS
Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870
[TBL] [Abstract][Full Text] [Related]
17. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
[TBL] [Abstract][Full Text] [Related]
18. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
Yang CC; Yang H
Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
[TBL] [Abstract][Full Text] [Related]
19. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
[TBL] [Abstract][Full Text] [Related]
20. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
